Filing Details
- Accession Number:
- 0001474506-25-000090
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-14 17:58:18
- Reporting Period:
- 2025-05-12
- Filing Date:
- 2025-05-14
- Accepted Time:
- 2025-05-14 17:58:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1894525 | Apimeds Pharmaceuticals Us Inc. | APUS | Pharmaceutical Preparations (2834) | 851099700 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2041972 | Jakap Koo | C/O Apimeds Pharmaceuticals Us, Inc. 2 East Broad Street, 2Nd Floor Hopewell NJ 08425 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.01 Per Share | Acquisiton | 2025-05-12 | 28,500 | $1.99 | 643,885 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Apimeds Pharmaceuticals US, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
- These shares were sold in multiple transactions at prices ranging from $1.9774 to $2.2000, inclusive.
Billionaire Hedge Funds
